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Abstract
Background: Disseminated leishmaniasis is an emerging infectious disease, mostly due to L.
braziliensis, which has clinical and histopathological features distinct from cutaneous leishmaniasis.
Methods: In the current study we evaluated the in vitro production of the cytokines IFN-γ, TNF-
α, IL-5 and IL-10 by peripheral blood mononuclear cells (PBMC) from 15 disseminated
leishmaniasis and 24 cutaneous leishmaniasis patients upon stimulation with L. braziliensis antigens
genotyped as disseminated leishmaniasis or cutaneous leishmaniasis isolates.
Results: Regardless of the source of L. braziliensis antigens, PBMC from cutaneous leishmaniasis
patients produced significantly higher IFN-γ than PBMC from disseminated leishmaniasis patients.
Levels of TNF-α by PBMC from cutaneous leishmaniasis patients were significantly higher than
disseminated leishmaniasis patients only when stimulated by genotyped cutaneous leishmaniasis
antigens. The levels of IL-5 and IL-10 production by PBMC were very low and similar in PBMCs
from both disseminated leishmaniasis and cutaneous leishmaniasis patients. The immune response
of each patient evaluated by the two L. braziliensis antigens was assessed in a paired analysis in which
we showed that L. braziliensis genotyped as disseminated leishmaniasis isolate was more potent than
L. braziliensis genotyped as cutaneous leishmaniasis isolate in triggering IFN-γ and TNF-α
production in both diseases and IL-5 only in cutaneous leishmaniasis patients.
Conclusion: This study provides evidence that antigens prepared from genotypically distinct
strains of L. braziliensis induce different degrees of immune response. It also indicates that both
parasite and host play a role in the outcome of L. braziliensis infection.
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Leishmania are obligate intracellular protozoa transmitted
to mammals by infected sand flies. Human infection
ranges from asymptomatic to tegumentary and visceral
disease, with disfiguring and fatal outcomes in the most
severe cases [1]. American tegumentary leishmaniasis
(ATL) presents a spectrum of clinical manifestations
including cutaneous (CL), mucosal (ML), disseminated
(DL) and diffuse cutaneous leishmaniasis [2,3]. DL
caused by L. braziliensis is an emerging infectious disease
mainly observed in Northeastern Brazil. DL is character-
ized by numerous acneiform, papular, nodular and ulcer-
ated skin lesions, distributed in two or more body parts
[4-7]. Most importantly, compared to only 3% among CL
patients develop mucosal leishmaniasis, up to 28% of DL
cases develop mucosal lesions, and the majority manifest
mucosal disease concurrent with cutaneous lesions at dis-
ease presentation [7].
Previous studies with small numbers of DL patients have
suggested that they often present a negative Leishmania
skin test and that their lymphocytes produce lower levels
of Th1 cytokines upon antigen stimulation than those of
CL individuals [7]. In addition to the roles of host genetics
and immune responses, evidence has been accumulated
on the intra-species variability among Leishmania sp, and
its importance in the development of different clinical
forms of leishmaniasis [8-12]. Analyses employing tech-
niques like multilocus enzyme electrophoresis (MLEE)
and rRNA gene internal transcribed spacers PCR-RFLP
(ITR) showed a high degree of polymorphism between
isolates of L. braziliensis from different regions. Moreover,
our recent analyses of the populations of parasites in the
ATL endemic area of Corte de Pedra (CP), northeastern
Brazil, revealed polymorphism among L. braziliensis iso-
lates and associations between genotypes and disease out-
come [8].
In this work to discern whether parasite factors influence
outcome of infection towards one of these two forms of
ATL, we assessed the production of IFN-γ, TNF-α, IL-5 and
IL-10 through the stimulation in vitro of peripheral blood
mononuclear cells (PBMC) from DL and CL patients with
L. braziliensis antigens isolated from DL and CL patients.
Methods
Subjects
The patients enrolled in this study were recruited at the
Corte de Pedra Health Post, situated in the southeast
region of the State of Bahia, Brazil. The inclusion criteria
were diagnosis of CL and DL with the presence of active
skin lesions, and age from 10 to 60 years. The exclusion
criteria were pregnancy, AIDS and other immunosuppres-
sive conditions, as well as the patient's desire of being
excluded from the study. Participants of this study
included 15 DL patients presenting with 10 or more
mixed-type lesions (acneiform, papular, nodular and/or
ulcerated) in two or more body parts (head, trunk, arms
and legs), and 24 CL patients presenting with ulcerated
lesions localized in a single body part. The diagnosis was
confirmed by culture identification of Leishmania in lesion
biopsy or in aspirates, or by histopathology typical of
leishmaniasis and a positive Leishmania skin test.
This study has been approved by the Ethical Committee of
the Hospital Universitário Professor Edgard Santos and
informed consent was obtained from all prospectively
enrolled patients.
Parasites
Two promastigotes of L braziliensis, one from a patient
with CL and the other from a patient with DL, each geno-
typed by RAPD protocols were used as antigen sources for
the in vitro cytokine induction assays. The molecular gen-
otyping of parasites was made by four RAPD protocols as
previously described [8]. Cutaneous leishmaniasis L. bra-
ziliensis isolate belonged to CL enriched L. braziliensis
clade B of CP, while the DL isolate belonged to the DL
enriched clade D of CP. Therefore, they are designated as
L. braziliensis genotyped as CL or DL isolates. In a small
number of patients experiments were repeated with two
other isolates from different patients with CL and DL. The
results were similar to these obtained with the original
isolates.
Isolation and cultivation of L braziliensis
The isolation of L. braziliensis was made in Navy McNeal
Nicoli (NNN) blood agar overlaid with a modified Liver
Infusion Tryptose (LIT) supplemented with 10% heat
inactivated fetal bovine serum medium (FCS) (Sigma
Chemical Co., St. Louis, MO) from samples obtained by
needle aspiration of the skin lesions. The cultures from
the biphasic medium were expanded for growth in Sch-
neider's insect medium (Sigma), supplemented with 10%
heat inactivated FCS at 25°C.
Leishmania antigens
Antigens used for in vitro stimulation of PBMC came from
isolates of L. braziliensis from CL and DL patients. Promas-
tigotes in the stationary-phase of growth were washed
three times by centrifugation, adjusted to a concentration
of 109 in Phosphate Buffered Saline (PBS), and disrupted
by eight repeated cycle of freezing (-70°C) and thawing
(37°C), followed by ultrasonication. The supernatants
were filtered at 0,45 υM Millipore and stored at -20°C
until use. The protein content was determined by the
Lowry method [13]. After performing a dose curve
response to determine the optimal dose, both antigens
were used in the concentration (10 µg/ml).Page 2 of 6
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PBMC were obtained from heparinized venous blood
from patients with CL and DL by density centrifugation
over a gradient of Ficoll-Hypaque (LSM; Organon Teknika
corporation, Durham, NC, USA). PBMC adjusted to a
concentration of 3 × 106 cells/ml were suspended in RPMI
1640 medium (GIBCO BRL., Grand Island, NY), 10%
heat-inactivated human AB serum, 2 mM L-glutamine,
100 U/ml penicillin and 100 µg/ml streptomycin
(GIBCO). The cells were distributed in 24-well plates and
stimulated with Leishmania antigens (10 µg/ml) and phy-
tohemaglutinin (PHA) (100 µg/ml, Sigma), and then
incubated for 72 hr at 37°C in 5% CO2 .
Cytokine determination
The supernatants were harvested and stored at -20°C for
cytokine determination [14]. Supernatants of cell cultures
from CL and DL patients were assayed for IFN-γ, TNF-α,
IL-5 and IL-l0 by sandwich ELISA technique (R & D sys-
tem, Minneapolis, MN) using a mouse anti-human
cytokine monoclonal antibody (mAb) as capture anti-
body. Purified cytokines at varying amounts were used to
derive a standard curve (R & D system, Minneapolis, MN).
The sensitivities of the cytokine dosage assays were 8 pg/
ml (for IFN-γ), 4.4 pg/ml (for TNF-α), 3.9 pg/ml (for IL-
5) and 3.9 pg/ml (for IL-10). IL-4 was not measured
because of the low sensitivity of the technique in detecting
IL-4 in supernatants of PBMC from humans.
Statistical analysis
Comparison of the levels of cytokine produced by PBMC
from CL and DL patients was made by the Mann-Whitney
test. The paired analyses were conducted by Wilcoxon
paired non-parametric test; significance was determined
as p < 0.05 (two tailed).
Results
The production of IFN-γ and TNF-α by peripheral blood
mononuclear cells (PBMC) from CL and DL patients stim-
ulated with antigens from L. braziliensis genotyped isolates
are shown in figure 1. In vitro IFN-γ production by PBMC
from CL patients was significantly higher than DL patients
regardless of whether the source of antigen was L. bra-
ziliensis genotyped as a CL or DL isolate (8810 ± 13422
pg/ml versus 1849 ± 1683 pg/ml or 11873 ± 16184 pg/ml
versus 2791 ± 1881 pg/ml, respectively; P = 0.02 or = 0.01,
respectively) (Figure 1A). TNF-α production by PBMC
from CL patients was significantly greater than DL
patients in response to L. braziliensis antigen from a CL
isolate. Even though L. braziliensis antigen from a DL iso-
late triggered higher TNF-α production by CL patients
than DL patients (4400 ± 5262 pg/ml versus 1729 ± 1603
pg/ml) the difference did not reach statistical significance
(Figure 1B, P = 0.08). The observed finding of higher lev-
els of IFN-γ and TNF-α production by CL patients
appeared to be specific because PBMC from CL and DL
patients responded to the mitogen, PHA, by producing
similar amounts of IFN-γ and TNF-α. We also evaluated
whether the response of each patient in the specific dis-
ease group was influenced by the source of the L. brazilien-
sis antigens. The aim was to compare IFN-γ and TNF-α
levels of CL patients to the two L. braziliensis antigens and
the immune response of DL patients to the two L. bra-
ziliensis antigens. Using a paired analysis, L. braziliensis
antigens from a DL isolate compared to a CL isolate trig-
gered significantly greater (P < .05) IFN-γ and TNF-α pro-
IFN-γ and TNF-α production induced by antigens from L. bra-ziliensis isolates isolated CL or DL casesFigure 1
IFN-γ and TNF-α production induced by antigens 
from L. braziliensis isolates isolated CL or DL cases. 
PBMCs from cutaneous leishmaniasis (CL) (hatched bars, n = 
24) and disseminated leishmaniasis patients (black bars, n = 
15) were stimulated with antigens of L. braziliensis genotyped 
isolate from cutaneous leishmaniasis (Ag-CL) and dissemi-
nated leishmaniasis (Ag-DL). Data represent mean ± stand-
ard error mean (SEM) of supernatants collected and assayed 
by ELISA for (A) IFN-γ, *P < 0.02 and **P < 0.01, Mann-Whit-
ney test; +P < 0.005 and ++P < 0.001, Wilcoxon paired non-
parametric test; and for (B) TNF-α, *P < 0.03 and **P < 0.8, 
Mann-Whitney test; +, ++P < 0.001, Wilcoxon paired non-
parametric test.
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1A e 1B).
We next tested IL-5 and IL-10 from the same supernatant
previously assayed for IFN-γ and TNF-α. The levels of IL-5
and IL-10 produced by PBMC from patients with CL and
DL were similar (Figure 2A). The response of each patient
in the CL and DL groups to the two L. braziliensis antigens
was also evaluated and showed that L. braziliensis antigens
from a DL isolate triggered significantly higher IL-5 pro-
duction than antigens from a CL isolate by PBMC from CL
patients. Such a difference was not observed when tested
by PBMC from DL patients (Figure 2A). Levels of IL-10
production by PBMCs from CL and DL patients were sim-
ilarly low in response to antigens from L. braziliensis CL
isolate (6 ± 5 pg/ml and 9 ± 14 pg/ml (mean + SD)) and
L. braziliensis DL isolate (8 ± 12 pg/ml and 9 ± 16 pg/ml),
P = 0.41 and P = 0.41, respectively (Figure 2B). Over 50%
of the CL and DL patients' PBMC cultures had undetecta-
ble levels of IL-10.
Discussion
Disseminated leishmaniasis is an emerging disease pre-
dominantly detected in the state of Bahia, Brazil [4,5,7].
Although L. amazonensis and L. braziliensis have been
reported to be associated with DL in the past, only L. bra-
ziliensis has recently been consistently implicated with this
disease [7]. Furthermore, we have recently demonstrated
that certain L. braziliensis genotypes are more associated
with DL in areas of endemicity for ATL [8]. In the current
study we evaluated the production of IFN-γ, TNF-α, IL-5
and IL-10 of PBMC from DL and CL patients, showing
that DL patients produce less IFN-γ and TNF-α than those
with CL upon antigen stimulation, while the two groups
of individuals present similar IL-5 and IL-10 secretion. In
addition, we found that antigen from parasites of DL ori-
gin is a stronger inducer of the above pro-inflammatory
cytokines. These data concur with results from previous
work in our lab, in which we demonstrated that PBMC
from DL stimulated in vitro with antigens of L. amazonensis
produced lower levels of pro-inflammatory cytokines
than those of CL individuals [7]. Reinforcing these find-
ings, it has been shown that biopsies from CL patients dis-
play a higher intensity of IFN-γ expression than those of
DL individuals [15]. While lower levels of IFN-γ and TNF-
α may contribute to the dissemination of the disease, they
may also play a part in the different clinical aspects of the
lesions observed in these two clinical forms of L. brazilien-
sis. These pro-inflammatory cytokines may play key roles
in the defense mechanism against Leishmania, but may
also be involved in the formation of the immune medi-
ated ulcers of CL [16,17]. Therefore, in contrast to the CL
patients who develop large ulcers with infiltration of lym-
phocytes in the lesions and absent or few parasites, DL
individuals present multiple lesions, frequently over 100,
in different parts of their body. These lesions are mostly
non-ulcerated and small, and the parasites are more easily
documented [5].
Studies performed in Ethiopia on the stimulation of
PBMC from CL and diffuse cutaneous leishmaniasis, a
disease clinical and pathologically distinct from DL, have
shown that PBMC from CL produce more IFN-γ when
stimulated with L. aethiopica antigen from CL than by anti-
gen from diffuse cutaneous leishmaniasis. Interestingly,
lymphocyte proliferation among control individuals of
that endemic area was higher in response to CL antigen
than diffuse cutaneous leishmaniasis antigen, supporting
the idea that differences in the parasites may contribute to
the clinical outcome of infection with L. aethiopica [18].
Unlike L. aethiopica, L. braziliensis does not cause diffuse
cutaneous leishmaniasis and is predominantly associated
IL-5 and IL-10 production induced by antigens from L. bra-ziliensis isolates isolated CL or DL casesFigure 2
IL-5 and IL-10 production induced by antigens from 
L. braziliensis isolates isolated CL or DL cases. Data of 
cutaneous leishmaniasis patients (hatched bars) and dissemi-
nated leishmaniasis patients (black bars) are illustrated as the 
mean ± SEM of the same supernatants from Figure 1 assayed 
by ELISA for IL-5 (A) *P = 0.07, **P = 0.13, Mann-Whitney 
test; +P < 0.008 and ++P < 0.08, Wilcoxon paired non-para-
metric test and IL-10 (B) *,**P = 0.4, Mann-Whitney test; +P 
= 0.5 and ++P < 0.4, Wilcoxon paired non-parametric test.
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immune response. While indicating phenotypic variabil-
ity among the strains, the observation that DL-borne L.
braziliensis induced significantly higher levels of IFN-γ and
TNF-α in cultures of PBMC from CL patients was still sur-
prising. We offer two possible explanations: (1) a bias in
the innate immune response, which might be determin-
ing the outcome of DL; and (2) an over modulation of
production of these cytokines by regulatory T lym-
phocytes in DL individuals with carryover effects to the in
vitro evaluations. Both possibilities are currently being
evaluated.
IFN-γ and TNF-α are important cytokines for the outcome
of infection in the experimental models of leishmaniasis.
Type 1 immune responses are associated with control of
infection, while type 2 leads to susceptibility for Leishma-
nia sp [19]. In humans, low IFN-γ production has been
associated with parasite dissemination, as exemplified by
VL and diffuse cutaneous leishmaniasis [20-23], in which
IL-10 acts to down regulate IFN-γ [24]. In contrast to what
has been observed in VL and diffuse cutaneous leishmani-
asis, we found neither a type 2 immune response nor an
increase in IL-10 levels in DL patients [23,25]. However, it
was clear the type 1 immune response is impaired in DL
patients.
Conclusion
This study showed that regardless of the source of anti-
gens, CL patients produce more IFN-γ than DL patients.
Antigens from L. braziliensis genotyped as a DL isolate was
more potent than a CL isolate in promoting IFN-γ and
TNF-α production. This finding lends support for distinct
intraspecies differences and argues for the role of intraspe-
cies differences and host factors contributing to the clini-
cal outcome following L. braziliensis infection.
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